Resistance-Associated Mutations in the Human Immunodeficiency Virus Type 1 Subtype C Protease Gene from Treated and Untreated Patients in the United Kingdom
Patricia A. Cane(University of Birmingham), Deenan Pillay(Public Health England), Martin Wiselka(University Hospitals of Leicester NHS Trust), Annemiek de Ruiter(ViiV Healthcare (Spain)), Ray Fox(Gartnavel General Hospital), Philip Rice(St George's Hospital)
Cited by 85
Related Papers
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011
|AIDS|2014|397
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
|AIDS|2002|359
A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population
|Infectious Diseases and Therapy|2018|197